Rompe Pecho
- Product NDC
- 58593-265
- 11-digit product format
- 585930265
- Labeler code
- 58593
- Product ID
- 58593-265_411e96f1-d9a3-1820-e063-6294a90a8a69
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Guaifenesin
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- Efficient Laboratories, Inc.
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 1999-03-01
- Substance
- GUAIFENESIN
- Active strength
- 100 mg/5mL
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 58593-265 | 58593-265-04 | D | Discontinued by firm | 2026-10-21 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rompe Pecho
- Brand name suffix
- SF
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GUAIFENESIN | 100 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 495W7451VQ | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 31ff48fc-9603-413c-ab7c-2598b3e08f9c | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906 | Product name | 7 | 20210625 |
| 4fe95224-f543-4dbb-9445-8cca122b48c8 | Product name | 1 | 20150609 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 106ff02a-57e1-4c4c-a307-fd582ff4e311 | Product name | 1 | 20150212 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 58593-265-04 | 2023-08-03 | Drug Facts |
| 58593-265-04 | 2023-08-03 | Drug Facts |
| 58593-265-06 | 2023-08-03 | Drug Facts |
| 58593-265-06 | 2023-08-03 | Drug Facts |
| 58593-265-04 | 2023-07-28 | Drug Facts |
| 58593-265-04 | 2023-07-28 | Drug Facts |
| 58593-265-06 | 2023-07-28 | Drug Facts |
| 58593-265-06 | 2023-07-28 | Drug Facts |
| 58593-265-04 | 2020-02-16 | Drug Facts |
| 58593-265-04 | 2020-02-16 | Drug Facts |
| 58593-265-06 | 2020-02-16 | Drug Facts |
| 58593-265-06 | 2020-02-16 | Drug Facts |
| 58593-265-04 | 2020-01-31 | Drug Facts |
| 58593-265-04 | 2020-01-31 | Drug Facts |
| 58593-265-06 | 2020-01-31 | Drug Facts |
| 58593-265-06 | 2020-01-31 | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58593-265-04 | Rompe PechoSF | 118 mL in 1 BOTTLE | LIQUID | 118 | 15 | |
| 58593-265-06 | Rompe PechoSF | 178 mL in 1 BOTTLE | LIQUID | 178 | 15 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Herbal Flavor Menthol Cough Drops | HERBAL FLAVOR MENTHOL COUGH DROPS | WHOLE FOODS MARKET, INC. | 1eb848b6-3dec-5b5f-e063-6394a90aea14 | 2024-08-02 | Warnings | M012 |
| Menthol Cough Drops | MENTHOL COUGH DROPS | WHOLE FOODS MARKET, INC. | 1eb8927b-22c5-2ca3-e063-6294a90aa563 | 2024-08-02 | Warnings | M012 |
| No Drip Severe Anefrin Nasal | 0.05% OXYMETAZOLINE HCL | Walgreens Company | c126e969-56f3-47b4-a011-02ff150eccb8 | 2024-08-02 | Warnings | M012 |
| nasal | OXYMETAZOLINE HYDROCHLORIDE | Rite Aid Corporation | 90e0426b-654f-4bcd-8b1d-cf56d1fc0c68 | 2024-07-27 | Warnings | M012 |
| nasal decongestant | OXYMETAZOLINE HCL | A-S Medication Solutions | 0e81a937-59e5-4869-8ffb-c758fb37230d | 2024-07-23 | Warnings | M012 |
| WesTussin DM | DEXCHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | Westminster Pharmaceuticals, LLC | 68a0cd44-3fdd-430e-af1a-498d4415ab78 | 2024-07-23 | Warnings | M012 |
| Allergy Relief | DIPHENHYDRAMINE HCL 25 MG | Lil' Drug Store Products, Inc. | edc244d6-eb0b-d3c9-e053-2a95a90a2622 | 2024-07-22 | Warnings | M012 |
| Night Time Sleep Aid | DIPHENHYDRAMINE HCL | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 1f3eeb6c-4c44-4e2a-ad72-12c95e6589c9 | 2024-07-22 | Warnings | M012 |
| CareOne Childrens Allergy Relief | DIPHENHYDRAMINE HCL | American Sales Company | bb78ef2c-4f42-4e8f-b38d-f9b2965a384b | 2024-07-19 | Warnings | M012 |
| dg health allergy childrens | DIPHENHYDRAMINE HYDROCHLORIDE | Dolgencorp, LLC | 71445443-34bd-4d8c-b9c8-e7c3b8d4c832 | 2024-07-19 | Warnings | M012 |
| basic care childrens allergy relief | DIPHENHYDRAMINE HCL | Amazon.com Services LLC | 75b9ee90-ad26-433e-8b90-97441b8d1e15 | 2024-07-19 | Warnings | M012 |
| Cold and Flu Severe Day and Night | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC | 9b74dd00-8f84-4fce-b5ea-df886b595326 | 2024-07-18 | Warnings | M012 |
| Cold plus Flu Severe | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 4872dfdd-0df6-47ae-87f2-8049191cd482 | 2024-07-18 | Warnings | M012 |
| equate allergy relief | DIPHENHYDRAMINE HYDROCHLORIDE | Wal-Mart Stores Inc | b05acd16-21cb-4ee0-afa0-8f7d59166435 | 2024-07-18 | Warnings | M012 |
| Childrens Allergy | DIPHENHYDRAMINE HCL | Publix Super Markets Inc | cc6e4e26-84f5-4003-b1eb-f0e06d3e294e | 2024-07-18 | Warnings | M012 |
| childrens allergy | DIPHENHYDRAMINE HYDROCHLORIDE | Kroger Company | 10ebc7f8-dc8a-4640-8f87-d0d073998fd5 | 2024-07-18 | Warnings | M012 |
| Good Neighbor Pharmacy Childrens Allergy | DIPHENHYDRAMINE HYDROCHLORIDE | Amerisource Bergen | b173cc2c-7c4c-4f9e-a920-c71bc256ec1e | 2024-07-18 | Warnings | M012 |
| ALLERGY | CHLORPHENIRAMINE MALEATE | A-S Medication Solutions | b199b5ee-fff3-4746-be68-a04060586f8e | 2024-07-18 | Warnings | M012 |
| Allergy | DIPHENHYDRAMINE HCL | H E B | 2d1715b3-b1cf-455d-9909-f6d58c97db40 | 2024-07-18 | Warnings | M012 |
| careone allergy relief | DIPHENHYDRAMINE HYDROCHLORIDE | American Sales Company | ed4038fc-ab39-4567-9961-2b390b91b126 | 2024-07-17 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 310604 | guaiFENesin 100 MG in 5 mL Oral Solution | PSN | 31ff48fc-9603-413c-ab7c-2598b3e08f9c | 15 |
| 1112205 | Rompe Pecho 100 MG in 5 mL Oral Solution | PSN | 31ff48fc-9603-413c-ab7c-2598b3e08f9c | 15 |
| 1112205 | guaifenesin 20 MG/ML Oral Solution [Rompe Pecho] | SBD | 31ff48fc-9603-413c-ab7c-2598b3e08f9c | 15 |
| 310604 | guaifenesin 20 MG/ML Oral Solution | SCD | 31ff48fc-9603-413c-ab7c-2598b3e08f9c | 15 |
| 310604 | guaifenesin 100 MG per 5 ML Oral Solution | SY | 31ff48fc-9603-413c-ab7c-2598b3e08f9c | 15 |
| 310604 | guaifenesin 100 MG per 5 ML Oral Syrup | SY | 31ff48fc-9603-413c-ab7c-2598b3e08f9c | 15 |
| 310604 | guaifenesin 200 MG per 10 ML Oral Solution | SY | 31ff48fc-9603-413c-ab7c-2598b3e08f9c | 15 |
| 310604 | guaifenesin 300 MG per 15 ML Oral Solution | SY | 31ff48fc-9603-413c-ab7c-2598b3e08f9c | 15 |
| 310604 | guaifenesin 400 MG per 20 ML Oral Solution | SY | 31ff48fc-9603-413c-ab7c-2598b3e08f9c | 15 |
| 1112205 | Rompe Pecho 100 MG per 5 ML Oral Solution | SY | 31ff48fc-9603-413c-ab7c-2598b3e08f9c | 15 |
| 1112205 | Rompe Pecho 20 MG/ML Oral Solution | SY | 31ff48fc-9603-413c-ab7c-2598b3e08f9c | 15 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 58593-265-04 | 58593026504 | 118 mL in 1 BOTTLE (58593-265-04) | 118 ml | 2015-01-01 | 0000-00-00 | No | No | Current |
| 58593-265-06 | 58593026506 | 178 mL in 1 BOTTLE (58593-265-06) | 178 ml | 1999-03-01 | 0000-00-00 | No | No | Current |